ID   JF5
AC   CVCL_V085
DR   CLO; CLO_0007021
DR   CLDB; cl2941
DR   IHW; 11w 8005
DR   Wikidata; Q54898579
RX   PubMed=3894226;
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:914; B2M.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*11).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_K237 ! J27.2
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
RX   PubMed=3894226; DOI=10.1007/BF00430589;
RA   Paul P., Lepage V., Sayagh B., Metzger J.-J., Pla M., Boumsell L.,
RA   Douay C., Cohen D., Colombani J., Dausset J., Degos L.;
RT   "Serological expression after sequential double transfection with
RT   purified HLA-A11 gene of mouse fibroblasts carrying human beta-2
RT   microglobulin.";
RL   Immunogenetics 22:1-8(1985).
//